Your browser doesn't support javascript.
loading
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases.
Ozzoude, Miracle; Varriano, Brenda; Beaton, Derek; Ramirez, Joel; Adamo, Sabrina; Holmes, Melissa F; Scott, Christopher J M; Gao, Fuqiang; Sunderland, Kelly M; McLaughlin, Paula; Goubran, Maged; Kwan, Donna; Roberts, Angela; Bartha, Robert; Symons, Sean; Tan, Brian; Swartz, Richard H; Abrahao, Agessandro; Saposnik, Gustavo; Masellis, Mario; Lang, Anthony E; Marras, Connie; Zinman, Lorne; Shoesmith, Christen; Borrie, Michael; Fischer, Corinne E; Frank, Andrew; Freedman, Morris; Montero-Odasso, Manuel; Kumar, Sanjeev; Pasternak, Stephen; Strother, Stephen C; Pollock, Bruce G; Rajji, Tarek K; Seitz, Dallas; Tang-Wai, David F; Turnbull, John; Dowlatshahi, Dar; Hassan, Ayman; Casaubon, Leanne; Mandzia, Jennifer; Sahlas, Demetrios; Breen, David P; Grimes, David; Jog, Mandar; Steeves, Thomas D L; Arnott, Stephen R; Black, Sandra E; Finger, Elizabeth; Rabin, Jennifer.
Afiliação
  • Ozzoude M; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Krembil Discovery Tower, 60 Leonard Avenue, 6th floor 6KD-407, Toronto, ON, M5T 2S8, Canada.
  • Varriano B; L.C. Campbell Cognitive Neurology Unit, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Beaton D; Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
  • Ramirez J; Department of Psychology, Faculty of Health, York University, Toronto, ON, Canada.
  • Adamo S; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Krembil Discovery Tower, 60 Leonard Avenue, 6th floor 6KD-407, Toronto, ON, M5T 2S8, Canada.
  • Holmes MF; Central Michigan University College of Medicine, Mount Pleasant, MI, USA.
  • Scott CJM; Data Science & Advanced Analytic, St. Michael's Hospital, Toronto, ON, Canada.
  • Gao F; L.C. Campbell Cognitive Neurology Unit, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Sunderland KM; Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
  • McLaughlin P; Graduate Department of Psychological Clinical Science, University of Toronto Scarborough, Scarborough, ON, Canada.
  • Goubran M; L.C. Campbell Cognitive Neurology Unit, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Kwan D; Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
  • Roberts A; L.C. Campbell Cognitive Neurology Unit, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Bartha R; Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
  • Symons S; L.C. Campbell Cognitive Neurology Unit, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Tan B; Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
  • Swartz RH; Rotman Research Institute of Baycrest Centre, Toronto, ON, Canada.
  • Abrahao A; Nova Scotia Health, Halifax, NS, Canada.
  • Saposnik G; Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
  • Masellis M; Harquail Centre for Neuromodulation, Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Lang AE; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Marras C; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Zinman L; Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada.
  • Shoesmith C; Queen's University, Kingston, ON, Canada.
  • Borrie M; Roxelyn and Richard Pepper Department of Communication Sciences and Disorders, Northwestern University, Evanston, IL, USA.
  • Fischer CE; School of Communication Sciences and Disorders, Faculty of Health Sciences, Western University, London, ON, Canada.
  • Frank A; Robarts Research Institute, Western University, London, ON, Canada.
  • Freedman M; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Montero-Odasso M; Rotman Research Institute of Baycrest Centre, Toronto, ON, Canada.
  • Kumar S; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Pasternak S; Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada.
  • Strother SC; Heart & Stroke Foundation Canadian Partnership for Stroke Recovery, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Pollock BG; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Rajji TK; Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada.
  • Seitz D; Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Tang-Wai DF; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Turnbull J; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Dowlatshahi D; Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada.
  • Hassan A; Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada.
  • Casaubon L; Edmond J Safra Program for Parkinson Disease, Movement Disorder Clinic, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.
  • Mandzia J; Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada.
  • Sahlas D; Edmond J Safra Program for Parkinson Disease, Movement Disorder Clinic, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.
  • Breen DP; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Grimes D; Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada.
  • Jog M; Department of Clinical Neurological Sciences, Western University, London, ON, Canada.
  • Steeves TDL; Robarts Research Institute, Western University, London, ON, Canada.
  • Arnott SR; Department of Clinical Neurological Sciences, Western University, London, ON, Canada.
  • Black SE; Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
  • Finger E; Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Rabin J; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
Alzheimers Res Ther ; 15(1): 114, 2023 06 20.
Article em En | MEDLINE | ID: mdl-37340319
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Transtornos Cerebrovasculares / Demência Frontotemporal / Disfunção Cognitiva / Substância Branca Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Transtornos Cerebrovasculares / Demência Frontotemporal / Disfunção Cognitiva / Substância Branca Idioma: En Ano de publicação: 2023 Tipo de documento: Article